Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy - Trial NCT01233479
Access comprehensive clinical trial information for NCT01233479 through Pure Global AI's free database. This phase not specified trial is sponsored by Pediatric Brain Tumor Consortium and is currently Withdrawn. The study focuses on Brain and Central Nervous System Tumors. Target enrollment is 0 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Pediatric Brain Tumor Consortium
Timeline & Enrollment
N/A
May 01, 2010
Aug 24, 2017
Primary Outcome
Peripherally circulating T-regulatory (T-reg) cells in patients with medulloblastoma or Chiari malformation,Longitudinal side effects of standard radiotherapy and chemotherapy regimens on the overall population of lymphocytes as well as the fraction of circulating T-reg cells,Effect of treatment on lymphocytes and T-reg cells
Summary
RATIONALE: Studying samples of blood in the laboratory from patients receiving radiation
 therapy and chemotherapy may help doctors learn more about the effects of this treatment on
 cells. It may also help doctors understand how well patients respond to treatment.
 
 PURPOSE: This research study is studying biomarkers in blood samples from young patients with
 newly diagnosed brain tumors undergoing standard radiation therapy and chemotherapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01233479
Non-Device Trial